Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Nature Reviews Gastroenterology & Hepatology, Published online: 06 December 2023; doi:10.1038/s41575-023-00880-2Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and chronic kidney disease. Successful treatment of steatotic liver disease might also be effective in preventing these cardiometabolic diseases.
Source: Nature Reviews Gastroenterology and Hepatology - Category: Gastroenterology Authors: Norbert Stefan Amedeo Lonardo Giovanni Targher Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Gastroenterology | Heart | Liver | Liver Disease | Urology & Nephrology